Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Saudi Arabia Market to Grow Significant Rate
According to TechSci Research report, “Saudi Arabia Medical Devices Market By Type (Cardiovascular Devices, Diagnostic […]
Hancock: Modern Medicine May Cease to Exist Without Global AMR Action
Health and Social Care Secretary, Matt Hancock, will today call for urgent global action in […]
June Medical Honoured with Queen’s Award
Galaxy II earns a Queen’s Award for Enterprise for Innovation June Medical are revelling in […]
Co-Diagnostics, Inc. JV CoSara Diagnostics Recognized for Work Combating COVID-19 Surge in India
Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the […]
NHS Digital Appoints Simon Bolton as Interim CEO
NHS Digital has announced today that Simon Bolton has been appointed as its interim CEO. […]
MD Ally Announces $3.5M Seed Round to Connect 9-1-1 and First Responders to Telehealth, Mental Health and Social Services
MD Ally, a 911-powered telehealth company, today announced a $3.5M seed round to expand the […]
Hurdle Appoints Behavioral Health Executive Krystle Herbert as New Head of Clinical Care
Hurdle, an innovative digital mental-health platform company, announced today that Krystle Herbert has joined the […]
ERT and Bioclinica Close Merger, Creating the Global Leader in Clinical Trial Endpoint Technology
ERT, a global leader in clinical endpoint data solutions, today announced the close of its […]
GEN inCode Announces Major UK Collaboration
GEN inCode UK Limited, the cardiovascular disease company focused on predictive genetics for the prevention […]
Caresyntax Raises $100 Million
Caresyntax, the leading enterprise-level digital surgery platform delivering actionable insights to make surgery smarter and […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more